TrialJournal of diabetes2024

Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24-week, randomized, double-blind, active-controlled, phase 3 trial.

Lingding Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.